Provided by Tiger Fintech (Singapore) Pte. Ltd.

IDEXX Laboratories

648.24
+2.590.40%
Volume:97.51K
Turnover:62.89M
Market Cap:51.86B
PE:53.97
High:648.49
Open:644.59
Low:643.40
Close:645.65
52wk High:688.12
52wk Low:356.14
Shares:80.00M
Float Shares:79.12M
Volume Ratio:1.82
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):12.01
EPS(LYR):10.77
ROE:64.87%
ROA:23.26%
PB:35.55
PE(LYR):60.21

Loading ...

Aug 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2025

Major Issues Report

Form 8-K - Current report
Jul 10, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Correspondence

Form CORRESP - Correspondence
May 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Correspondence

Form CORRESP - Correspondence
Feb 21, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]